ODDB.org: Open Drug Database

Home - 61385

Swissmedic Registration	61385	Date of registration	29.05.2012
Company name	Boehringer Ingelheim (Schweiz) GmbH	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	06.03.20.	Revocation Date
Index Therapeuticus (Swissmedic)	06.03.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
02	Pradaxa 110 mg	Kapseln	Capsules (Dabigatranum Etexilatum 110 mg)	B01AE07	CI
03	Pradaxa 150 mg	Kapseln	Capsules (Dabigatranum Etexilatum 150 mg)	B01AE07	CI

2025	©ywesee GmbH